potential for complementing abl and possibly other oncogenes to induce transformation of a variety of cell types.
In this study we undertook an examination of a large series of hematopoietic tumors for the presence of the 6C3 antigen, gp1606cs was found on most Blineage spontaneous tumors and each B-lineage tumors induced by replicationdefective MuLV containing the oncogenesfes, abl, H-ras, bas, src, erbB, and Cas NS-1, but not on T cell lymphomas, or myelomonocytic leukemias or erytholeukemias . By comparison, none of the early B-lineage lymphomas induced by v-myc or involving translocated c-myc sequences bear the antigen.
Materials and Methods Cells. Cell lines containing abl, fes, ras (including Ha-ras, Ki-ras, and bas), src and erbB were produced by infection of fetal liver or bone marrow cells in vitro with Moloney or 4070A pseudotypes, or with replication-defective viruses, as described (4) . Cell lines induced by Friend spleen focus-forming virus (F-SFFV) and Cas NS-1 were adapted to growth in vitro from primary tumors or passaged in vivo . Five in vitro-adapted cell lines from A-MuLV plasmacytoid lymphosarcoma (ABPL) tumors with 5'-truncated myb genes have been shown to be of myelomonocytic origin (G. L. C. Shen-Ong, K. L. Holmes, H. C. Morse, III, manuscript submitted for publication) . One IL-3-dependent cell line with a 3'-truncated myb gene and myeloid characteristics has been described (15) .
Viruses. Virologic characteristics of CWD/Agl (12), Bio.NZN (13) , and NFS.Akv-1 (14) mice are published. Data concerning the structure and transforming activities of J-3, J-5, J-2, and J-1 recombinant viruses are presented elsewhere (6) . Northern blot hybridization studies of mRNA produced by Cas NS-I-transformed pre-B cells indicate that the Cas NS-1 transforming gene is unrelated to abl, myc, myb, Ki-ras, mos, fos, raf, erbB, fms, sis, Pim-1, src, p53, ets, fes, or bcl-2 (11) .
Characterization of Tumors. All the tumors were characterized as to cell lineage and state of differentiation by flow microfluorometry (FMF) studies using a large panel of antibodies to cell surface antigens (4, 8) . Gross and histological studies were carried out on tissues obtained at autopsy from mice .
Polyacrylamide Gel Electrophoresis . Immunoprecipitation and SDS-PAGE have been described before (9) .
Results
To determine if expression of gp 1606cs is limited predominantly to pre-B cells induced by A-MuLV, we analyzed a large series of hematopoietic tumors for expression of this antigen (Table I ) . All the tumors diagnosed as T cell lymphomas were Thy-1 + and variably expressed Ly-1, Ly-2, L3T4, or Tla. Pre-B cell lymphomas were all surface immunoglobulin (slg)-negative and Lyb-2', and consisted mostly of large pre-B cell tumors . The B cell lymphomas were uniformly sIg' and all plasmacytomas were PC-1 +. The diagnosis of erythroleukemia was made primarily on histologic grounds, as these tumors are predominantly null for the antibodies used in the FMF studies (8) . Finally, all the myelomonocytic tumors were Mac-1 +, Ly-17+ (alleles of Ly-17 define polymorphisms of the Fc-y-R) and most were la'. Studies of these tumors for expression of the 6C3 antigen showed that, with one exception, only tumors of the B lymphocyte lineage were 6C3+ . Thus, 53 of 59 (90%) pre-B cell lymphomas and 15 of 31 (48%) B cell lymphomas were 6C3+, whereas none of the 44 T cell lymphomas or 11 erythroleukemias expressed this antigen (Table I ) . The only one of 13 myelomonocytic tumors found to be 6C3+ was the macrophage cell line, P388D1 . This apparent discrepancy may be explained by the recent finding that this tumor has many characteristics of cells in the B lymphocyte lineage, including expression of Lyb-2 and Ly-5 (13220), and rearrangements of Ig heavy and light chain genes (16) .
Almost all of the pre-B cell lymphomas induced by retroviruses containing the Cas NS-1 transforming gene, abl, ras (including H-ras, Ki-ras, and bas), fes, src, or erbB were 6C3+. By comparison, none of 20 pre-B, B cell, or plasmacytic tumors induced by viruses expressing v-myc were positive for this antigen (Table  I ) . In addition, more than 10 pre-B lymphomas of mice transgenic for c-myc driven by Ig enhancer sequences (17) in Table I Comparisons of "'I-labeled cell surface proteins precipitated from a pre-B cell lymphoma (NFS-46'7) induced by the Cas NS-1 transforming virus and a pre-B cell lymphoma (L1-2) induced by A-MuLV showed that the predominant proteins reactive with 6C3 were of 159 and 160 kD, respectively (Fig . 1) . It is likely that the 6C3-reactive antigens present on cells transformed by A-MuLV and other replication-defective or -competent viruses are very similar, with molecular mass differences possibly reflecting variations in glycosylation of a common protein .
Discussion
These results demonstrate that expression of gpI60 scs antigen is often associated with neoplastic transformation ofearly B lymphocytes. These results support by tumor cells is confined to age (9) . Additionally, we present evidence here that the 6C3 antigen is expressed in early B leukemias that have been induced with a variety of "cytoplasmic", oncogenes but never with the "nuclear" myc oncogene . These findings suggest that alternative 6C3+ and 6C3-pathways may be involved in the transformation of B lineage cells with otherwise indistinguishable phenotypes . There is no evidence to suggest that mAb 6C3 defines leukemias of a B sublineage distinct from a sublineage transformed by myc .
If the assumption is made that transformation of normal B lineage cells, like other primary cells (2) , requires the interaction of at least two kinds of oncogene products (nuclear and cytoplasmic), there are several possible models for coexpression of the 6C3 antigen with a cytoplasmic but not a nuclear oncogene . For example, functions provided to normal cells by the gene encoding the 6C3 antigen may be similar to those provided by myc. The observation that this antigen is expressed on the surface of tumor cells is not incompatible with the suggestion that its location in normal cells is nuclear, but that like the simian virus 40 large T antigen, both nuclear and surface membrane functions can contribute to the immortalization and transformation of cells (18) . In a second model, aberrant expression of gp160 6cs on the cell surface may drive the expression of a nuclear oncogene that can complement the different cytoplasmic viral oncogenes for transformation of B lineage cells. In either model, the provision of a nuclear signal via deregulated myc expression would preclude the requirement to engage either the nuclear or surface membrane functions postulated for the 6C3 antigen. In a third model, different cytoplasmic oncogenes may indirectly induce or augment expression of the gene encoding gp160 6C3 in a way unrelated to any contribution of the antigen to the induction or maintenance of the transformed phenotype. While several other models are also possible, each of the above leads to a specific, testable prediction .
Summary
The monoclonal antibody 6C3 was used to test a wide variety of murine hematopoietic neoplasms for cell surface expression of a 160 kD glycoprotein (gp 160 6c3) previously shown to be expressed by neoplastic pre-B and some B lymphocytes transformed by Abelson murine leukemia virus (A-MuLV) . This antigen was expressed on many pre-B and B cell lymphomas, but not on AMuLV-transformed fibroblasts, T cell lymphomas, or myelomonocytic leukemias. gp 1606cs was expressed by most early B-lineage spontaneous tumors, and early B tumors induced by replication-defective MuLV-containing oncogenes the products of which are associated with the cytoplasmic aspect of the plasma membrane, i.e., fes, abl, H-ras, bas, src, erbB, and Cas NS-1 . By comparison, none of the early B lineage lymphomas induced by the "nuclear" oncogene avian vmyc MuLV, or arising in mice transgenic for a murine c-myc gene, or later B cell lineage stages bearing translocations of the c-myc locus expressed this antigen.
